Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2026 15:12 ET | Source: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
April 22, 2026 21:22 ET | Source: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
April 20, 2026 08:53 ET | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
February 23, 2026 12:40 ET | Source: Block & Leviton LLP

BREAKING: Gossamer Bio Investors Should Contact Block & Leviton to Potentially Recover Losses After Shares Fall Over 75%

Block & Leviton is investigating Gossamer Bio, Inc. (Nasdaq: GOSS) for potential securities fraud. Investors should contact the firm to recover losses.